This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Fibrostein, S.l., University of Valencia. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 52 
Years Active: 2015
Title: Ernesto López-Pascual: Innovator in Cancer Treatment
Introduction
Ernesto López-Pascual is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the development of therapeutic agents that target specific proteins involved in tumor growth.
Latest Patents
López-Pascual holds a patent for "GPBP-1 inhibition and its therapeutic use." This invention provides compositions that include anti-tumor agents and inhibitors of Goodpasture antigen binding protein, p21, and ABCC7. These compositions are designed for use in treating cancer, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, López-Pascual has worked with various organizations, including Fibrostein, S.L. and Universitat de València. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
López-Pascual has collaborated with notable colleagues such as Juan Saus and Francisco Revert-Ros. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Ernesto López-Pascual is a dedicated inventor whose work in cancer treatment has the potential to make a significant difference in the lives of patients. His innovative approach and commitment to research exemplify the spirit of invention in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile